Cullinan Therapeutics

cullinantherapeutics.com

cullinantherapeutics.com • Likely startup • New

Likely startup • New

Actively hiring

Oncology Therapeutics

Health Care

Immunology & Inflammation Therapeutics

Overview

Salaries

Products

People

Growth

Offices

Financials

Funding and backers

Backers

Foresite Capital, Nextech Invest

Momentum

0/100

no fresh signals

Tractionpublic signals, read monthly

Web presence

top 5%

of 133.2M domains by links, Common Crawl

Backed byfrom the funds' portfolios and accelerator catalogs

Similar startupsby what they do, their industry and backers

JadebiosciencesFounded 2024 • 201-500 employees • 6 roles

On a mission to transform the future of autoimmune care. Developing innovative therapies with the potential to redefine the standard of…

Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.

AlumisVenture round $40M · 2 yr ago • Founded 2021 • 11-50 employees • 4 roles

We are using a precision approach to develop therapies designed to transform the lives of patients with immune-mediated diseases.

ITM51-200 employees

At ITM, precision drives everything - from isotope manufacturing to cancer treatment—improving outcomes and delivering what patients and…

Hexagon BioSeries B $77.3M · 3 yr ago • Founded 2016 • 201-500 employees • 1 role

Novel ADC Payloads for Cancer Hexagon Bio is developing novel payload mechanisms for antibody-drug conjugates (ADCs) to overcome resistance…

Viridian TherapeuticsVenture round $27M · 6 yr ago • Founded 2020 • 51-200 employees

Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditions.

Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline. See how.